Détails sur JCO Precision Oncology Conversations, podcast de American Society of Clinical Oncology (ASCO)

Détails du podcast

Informations techniques et générales issues du flux RSS du podcast.

Site

RSS

Apple

Classements récents

Dernières positions dans les classements Apple Podcasts et Spotify.

Liens partagés entre épisodes et podcasts

Liens présents dans les descriptions d'épisodes et autres podcasts les utilisant également.

https://ascopubs.org/journal/po
113 partages
https://ascopubs.org/journal/po/podcast
60 partages
https://www.asco.org/news-initiatives/podcasts
21 partages

https://twitter.com/jcopo_asco
2 partages
https://twitter.com/JCOPO_ASCO?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
2 partages
https://twitter.com/JCOPO_ASCO
1 partage

https://www.science.org/
1 partage
https://www.science.org/journal/science
1 partage

Qualité et score du flux RSS

Évaluation technique de la qualité et de la structure du flux RSS.

Historique des publications

Répartition mensuelle des publications d'épisodes au fil des années.

Derniers épisodes publiés

Liste des épisodes récents, avec titres, durées et descriptions.

JCO PO Article Insights: CTCs as Biomarkers in GBM

mercredi 30 septembre 2026 • Durée 05:55

In this episode of JCO Precision Oncology Article Insights, host Jiasen He summarizes the article, "Beyond the Brain: Circulating Tumor Cells as a Tool for Diagnosis and Monitoring," by Lessi and colleagues.

LINK TO FULL TRANSCRIPT

Lire plusRéduire

A Decade of Data: JCO PO and the TAPUR Study

mercredi 16 septembre 2026 • Durée 33:21

JCO PO Editor-in-Chief Emeritus Dr. James Ford and Founding PI, ASCO TAPUR Study, Dr. Richard Schilsky discuss the 10-year anniversary of the Targeted Agent and Profiling Utilization Registry (TAPUR)™ Study and its relationship with the journal. Host Dr. Rafeh Naqash and guests discuss the inception/history of the TAPUR study, its future, and advances in precision medicine over the past decade.

LINK TO FULL TRANSCRIPT

Lire plusRéduire

JCO PO Article Insights: Breast Neuroendocrine Carcinoma Beyond Histology

mercredi 26 août 2026 • Durée 08:57

In this JCO PO Article Insights episode, host Carolyn Lineen summarizes the article, "Breast Neuroendocrine Carcinoma: Molecular Insights Beyond Histology" by Schwartz and colleagues.

LINK TO FULL TRANSCRIPT

Lire plusRéduire

cfDNA Epigenetics for Toxicity Monitoring

mercredi 19 août 2026 • Durée 26:23

JCO PO authors Dr. James Hadfield, Dr. Grace Yiqing Zhao, and Dr. Julia Elvin at AstraZeneca share insights into the JCO PO article, "Beyond Circulating Tumor DNA for Efficacy: Can We Use Cell-Free DNA to Detect and Monitor Toxicity Signals?" Host Dr. Rafeh Naqash and guests discuss emerging evidence that cfDNA methylation profiling provides sensitive, specific signals of tissue injury across multiple organs and clinical contexts.

LINK TO FULL TRANSCRIPT

Lire plusRéduire

JCO PO Article Insights: Clinical ctDNA Testing in Advanced Pediatric Solid Tumors

mercredi 29 juillet 2026 • Durée 08:39

In this episode of JCO PO: Article Insights, host Jiasen He summarizes the article, "Clinical Liquid Biopsy Testing for Detection of Actionable Genomic Alterations in Children and Young Adults With Advanced Solid Tumors on the GAIN Study," by Roberts and colleagues.

LINK TO FULL TRANSCRIPT

Lire plusRéduire

ALK+ Squamous and Adenosquamous NSCLC

mercredi 15 juillet 2026 • Durée 12:33

JCO PO author Dr. Emily Miao at Mass General Brigham Cancer Institute shares insights into the JCO PO article, "Clinicogenomic Characteristics and Treatment Outcomes of Patients With Advanced ALK-Rearranged Squamous and Adenosquamous Non–Small Cell Lung Cancers." Host Dr. Rafeh Naqash and Dr. Miao discuss the clinicogenomic characteristics and treatment outcomes of patients with ALK+ squamous and adenosquamous lung cancers and how these outcomes compare to those of patients with ALK+ adenocarcinoma treated with first-line alectinib.

LINK TO FULL TRANSCRIPT

Lire plusRéduire

JCO PO Article Insights: Genomics of MTAP Loss and Co-Alteration Landscape

mercredi 24 juin 2026 • Durée 06:56

In this JCO PO Article Insights episode, host Carolyn Lineen summarizes the article, "Genomics of MTAP Loss in >500,000 Solid Tumor Specimens Profiled Using Comprehensive Genomic Profiling Platforms" by Dean C. Pavlick and colleagues.

LINK TO FULL TRANSCRIPT

Lire plusRéduire

Immune Checkpoint Blockade in dMMR/MSI-H Advanced UTUC

mercredi 17 juin 2026 • Durée 29:39

JCO PO authors Dr. Matthew Campbell and Dr. Mohammad Moussa at The University of Texas MD Anderson Cancer Center and Baylor College of Medicine, Houston, Texas, share insights into their article, "Efficacy of Immune Checkpoint Blockade in Advanced Upper Tract Urothelial Cancer With DNA Mismatch Repair Deficiency or Microsatellite Instability." Host Dr. Rafeh Naqash and Drs. Campbell and Moussa discuss how the study findings suggest that dMMR/MSI-H may serve as a biomarker of sensitivity to single-agent ICIs in advanced UTUC.

LINK TO FULL TRANSCRIPT

Lire plusRéduire

JCO PO Article Insights: Dynamic Monitoring of Anti-EGFR Resistance in Metastatic Colorectal Cancer

mercredi 27 mai 2026 • Durée 09:47

In this JCO PO Article Insights episode, host Jordan Goldstein summarizes the article, "EXONERATE-TRaCE: A Liquid Biopsy for Tracking Response to Anti–Epidermal Growth Factor Receptor–Based Therapy in Metastatic Colorectal Cancer" byTakahashi, et al.

LINK TO FULL TRANSCRIPT

Lire plusRéduire

Phase II Study of Seribantumab in Tumors Harboring NRG1 Fusions

mercredi 20 mai 2026 • Durée 22:57

JCO PO author Dr. Tejas Patil at University of Colorado Cancer Center shares insights into the JCO PO article, "CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions". Host Dr. Rafeh Naqash and Dr. Patil discuss the anti-tumor activity and safety data of seribantumab from the CRESTONE study (NCT04383210).

LINK TO FULL TRANSCRIPT

Lire plusRéduire

Podcasts et contenus similaires

Autres podcasts ou contenus associés partageant des thèmes ou audiences similaires.

JCO Precision Oncology Conversations - Détails, épisodes et analyse

Détails du podcast

Classements récents

Apple Podcasts

Spotify

Liens partagés entre épisodes et podcasts

Qualité et score du flux RSS

Historique des publications

Derniers épisodes publiés

Podcasts Similaires Basées sur le Contenu

Apple Podcasts

Spotify

Podcasts Similaires Basées sur le Contenu

JCO Precision Oncology Conversations - Détails, épisodes et analyse

Détails du podcast

Classements récents

Apple Podcasts

Spotify

Liens partagés entre épisodes et podcasts

Other99+

X4

Science2

Qualité et score du flux RSS

Historique des publications

Derniers épisodes publiés

Podcasts et contenus similaires

Podcasts Similaires Basées sur le Contenu

Apple Podcasts

Spotify

Podcasts Similaires Basées sur le Contenu

Other99+

X4

Science2